Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

about

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

Item

http://www.wikidata.org/entity/Q47159841

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@en

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@nl

type

Item

label

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@en

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@nl

prefLabel

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@en

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@nl

P1476

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.

@en

P2093

Christopher R Cogle

http://www.w3.org/2001/XMLSchema#string

Leylah M Drusbosky

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Databases and web tools for cancer genomics study

International scoring system for evaluating prognosis in myelodysplastic syndromes

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Clinical effect of point mutations in myelodysplastic syndromes

Precision oncology for acute myeloid leukemia using a knowledge bank approach.

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Revised international prognostic scoring system for myelodysplastic syndromes.

P2888

s11899-017-0412-z

P304

478-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S11899-017-0412-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28913766

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

myelodysplastic syndrome

P932

5670191

http://www.w3.org/2001/XMLSchema#string